$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

The Herbal Composition Gangjihwan from Ephedra intermedia, Lithospermum erythrorhizon and Rheum palmatum Ameliorates Hepatic Inflammation and Fibrosis in Obese C57BL/6J Mice and HepG2 Cells 원문보기

Biomedical science letters = 대한의생명과학회지, v.23 no.2, 2017년, pp.144 - 153  

Yoon, Michung (Department of Biomedical Engineering, Mokwon University)

Abstract AI-Helper 아이콘AI-Helper

It was demonstrated that Gangjihwan (DF), which is the herbal composition composed of Ephedra intermedia, Lithospermum erythrorhizon, and Rheum palmatum, inhibits obesity and hepatic steatosis in high fat diet (HFD)-fed obese mice. The aim of this study was to determine the effects of DF on visceral...

주제어

AI 본문요약
AI-Helper 아이콘 AI-Helper

* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.

제안 방법

  • Statistical analysis was performed using analysis of variance followed by Turkey's post-hoc tests.
  • Therefore, the effects of DF on visceral obesity and visceral obesity-induced hepatic inflammation and fibrosis were examined in high fat diet (HFD)-induced obese C57BL /6J mice and HepG2 cells, and investigated the histological and molecular events involved in this process. The present results demonstrate that DF inhibits visceral obesity, infiltration of inflammatory cells into the liver, and hepatic collagen accumulation and that this process may be mediated by regulating the hepatic expression of inflammation and fibrosis genes.
  • , 2015). To determine the effect of DF on visceral obesity, HFD-fed obese mice were treated with DF-FW, DF-GA30, and DF-GA70 for 8 weeks. HFD-fed control mice had much higher visceral fat mass and visceral adipocyte size compared with LFD-fed normal mice.
  • To evaluate whether the inhibitory effects of DF on hepatic fibrosis in obese mice were associated with alterations of the expression of fibrosis genes such as TGFβ1, α smooth muscle actin (α-SMA), and collagen α1.

대상 데이터

  • DF was prepared from food-grade extracts of the three medicinal herbs (40% Ephedra intermedia, 40% Lithospermum erythrorhizon, and 20% Rheum palmatum; ex pressed as % dry weight of DF) (Hwalim, Busan, Korea). The proportions used in this study are same as those used to treat patients in local clinics of Korea.
  • The genes of interest were amplified from the synthesized cDNA using AccuPower® GreenStarTM qPCR PreMix (Bioneer, Deajeon, Korea) on an ExcyclerTM 96 Real Time Quantitative Thermal Block machine (Bioneer).
본문요약 정보가 도움이 되었나요?

참고문헌 (34)

  1. Angulo P. Nonalcoholic fatty liver disease. The New England Journal of Medicine. 2002. 346: 1221-1231. 

  2. Bataller R, Brenner DA. Liver fibrosis. Journal of Clinical Investigation. 2005. 115: 209-218. 

  3. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nature Medicine. 2005. 11: 183-190. 

  4. Canbay A, Feldstein A, Baskin-Bey E, Bronk SF, Gores GJ. The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse. Journal of Pharmacology and Experimental Therapeutics. 2004. 308: 1191-1196. 

  5. Cancello R, Tordjman J, Poitou C, Guilhem G, Bouillot JL, Hugol D, Coussieu C, Basdevant A, Bar Hen A, Bedossa P, Guerre-Millo M, Clement K. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes. 2006. 55: 1554-1461. 

  6. Cao L, Quan XB, Zeng WJ, Yang XO, Wang MJ. Mechanism of hepatocyte apoptosis. Journal of Cell Death. 2016. 9: 19-29. 

  7. Chan W, Tan A, Vethakkan S, Tah P, Vijayananthan A, Goh K. Non-alcoholic fatty liver disease in diabetics-prevalence and predictive factors in a multiracial hospital clinic population in Malaysia. Journal of Gastroenterology and Hepatology. 2013. 28: 1375-1383. 

  8. Charlton M. Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clinical Gastroenterology and Hepatology. 2004. 2: 1048-1058. 

  9. Chatzigeorgiou A, Chung KJ, Garcia-Martin R, Alexaki VI, Klotzsche-von Ameln A, Phieler J, Sprott D, Kanczkowski W, Tzanavari T, Bdeir M, Bergmann S, Cartellieri M, Bachmann M, Nikolakopoulou P, Androutsellis-Theotokis A, Siegert G, Bornstein SR, Muders MH, Boon L, Karalis KP, Lutgens E, Chavakis T. Dual role of B7 costimulation in obesity-related nonalcoholic steatohepatitis and metabolic dysregulation. Hepatology. 2014. 60: 1196-1210. 

  10. Curat CA, Miranville A, Sengenes C, Diehl M, Tonus C, Busse R, Bouloumie A. From blood monocytes to adipose tissueresident macrophages: induction of diapedesis by human mature adipocytes. Diabetes. 2004. 53: 1285-1292. 

  11. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006. 444: 881-887. 

  12. Diehl AM. Hepatic complications of obesity. Gastroenterology Clinics of North America. 2005. 34: 45-61. 

  13. Fan J. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China. Journal of Gastroenterology and Hepatology. 2013. 28: 11-17. 

  14. Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology. 2003. 125: 437-443. 

  15. Gomez-Lechon MJ, Donato MT, Martinez-Romero A, Jimenez N, Castell JV, O'Connor JE. A human hepatocellular in vitro model to investigate steatosis. Chemico-Biological Interactions. 2007. 165: 106-116. 

  16. Jeong S, Chae K, Jung YS, Rho YH, Lee J, Ha J, Yoon KH, Kim GC, Oh KS, Shin SS, Yoon M. The Korean traditional medicine Gyeongshingangjeehwan inhibits obesity through the regulation of leptin and PPARalpha action in OLETF rats. Journal of Ethnopharmacology. 2008. 119: 245-251. 

  17. Jeong S, Yoon M. Fenofibrate inhibits adipocyte hypertrophy and insulin resistance by activating adipose $PPAR{\alpha}$ in high fat diet-induced obese mice. Experimental & Molecular Medicine. 2009. 41: 397-405. 

  18. Koh JC, Loo WM, Goh KL, Sugano K, Chan WK, Chiu WY, Choi MG, Gonlachanvit S, Lee WJ, Lee WJ, Lee YY, Lesmana LA, Li YM, Liu CJ, Matsuura B, Nakajima A, Ng EK, Sollano JD, Wong SK, Wong VW, Yang Y, Ho KY, Dan YY. Asian consensus on the relationship between obesity and gastrointestinal and liver diseases. Journal of Gastroenterology and Hepatology. 2016. 31: 1405-1413. 

  19. Liang H, Zhang L, Wang H, Tang J, Yang J, Wu C, Chen S. Inhibitory effect of gardenoside on free fatty acid-induced steatosis in HepG2 hepatocytes. International Journal of Molecular Sciences. 2015. 16: 27749-27756. 

  20. Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histology in obese patients undergoing bariatric surgery. Journal of Hepatology. 2006. 45: 600-606. 

  21. Milic S, Stimac D. Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment. Digestive Diseases. 2012. 30: 158-162. 

  22. Mulder P, Morrison MC, Wielinga PY, van Duyvenvoorde W, Kooistra T, Kleemann R. Surgical removal of inflamed epididymal white adipose tissue attenuates the development of non-alcoholic steatohepatitis in obesity. International Journal of Obesity. 2016. 40: 675-684. 

  23. Park SH, Jeon WK, Kim SH, Kim HJ, Park DI, Cho YK, Sung IK, Sohn CI, Keum DK, Kim BI. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. Journal of Gastroenterology and Hepatology. 2006. 21: 138-143. 

  24. Petersen KF, Dufour S, Feng J, Befroy D, Dziura J, Dalla Man C, Cobelli C, Shulman GI. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proceedings of the National Academy of Sciences. 2006. 103: 18273 -18277. 

  25. Roh JS, Lee H, Woo S, Yoon M, Kim J, Park SD, Shin SS, Yoon M. Herbal composition Gambigyeongsinhwan from Curcuma longa, Alnus japonica, and Massa Medicata Fermentata inhibits lipid accumulation in 3T3-L1 cells and regulates obesity in Otsuka Long-Evans Tokushima Fatty rats. Journal of Ethnopharmacology. 2015. 171: 287-294. 

  26. Saile B, Matthes N, El Armouche H, Neubauer K, Ramadori G. The bcl, NFkappaB and p53/p21WAF1 systems are involved in spontaneous apoptosis and in the anti-apoptotic effect of TGF-beta or TNF-alpha on activated hepatic stellate cells. European Journal of Cell Biology. 2001. 80: 554-561. 

  27. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006. 118: 1388-1393. 

  28. Shin SS, Jung YS, Yoon KH, Choi S, Hong Y, Park D, Lee H, Seo BI, Lee HY, Yoon M. The Korean traditional medicine gyeongshingangjeehwan inhibits adipocyte hypertrophy and visceral adipose tissue accumulation by activating PPARalpha actions in rat white adipose tissues. Journal of Ethnopharmacology. 2010. 127: 47-54. 

  29. Tilg H, Moschen AR. Insulin resistance, inflammation, and nonalcoholic fatty liver disease. Trends in Endocrinology and Metabolism. 2008. 19: 371-379. 

  30. Van der Poorten D, Milner KL, Hui J, Hodge A, Trenell MI, Kench JG, London R, Peduto T, Chisholm DJ, George J. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology. 2008. 48: 449-457. 

  31. Vuppalanchi R, Chalasani N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. Hepatology. 2009. 49: 306-317. 

  32. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of Clinical Investigation. 2003. 112: 1821-1830. 

  33. Yoon S, Kim J, Lee H, Lee H, Lim J, Yang H, Shin SS, Yoon M. The effects of herbal composition Gambigyeongsinhwan on hepatic steatosis and inflammation in Otsuka Long-Evans Tokushima fatty rats and HepG2 cells. Journal of Ethnopharmacology. 2017. 195: 204-213. 

  34. Yu SJ, Kim W, Kim D, Yoon JH, Lee K, Kim JH, Cho EJ, Lee JH, Kim HY, Kim YJ, Kim CY. Visceral obesity predicts significant fibrosis in patients with nonalcoholic fatty liver disease. Medicine. 2015. 94: e2159. 

저자의 다른 논문 :

LOADING...
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로